Ikarian Capital, LLC
DALLAS TX · SEC CIK 0001778253
$12.32亿2026Q1 申报市值
161持仓数
42.5%前十大占比 · 第一大 8.3%
36 / 53新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
ALMS 新建仓+$2,673.45万
KOD 加仓+$2,081.38万
CLDX 新建仓+$1,463.08万
HROW 加仓+$1,268.30万
ORKA 新建仓+$1,187.11万
2026Q1 卖出最多 按季末市值估算
CIDARA THERAPEUT 清仓-$6,035.66万
JAZZ 减仓-$2,796.18万
RAPT THERAPEUTIC 清仓-$2,253.27万
ABVX 减仓-$1,604.27万
AMGN 清仓-$1,472.90万
2026Q1 持仓明细 点表头排序 · 每页 100 行
导出 CSV 🔒| 代码 | 名称 | 市值 ▲ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS INC | $1,871.10万 | 1.52% | 2,688,359 | -380,000 | -12.4% | -$264.48万 | 减仓 |
| HROW | HARROW INC | $1,914.78万 | 1.55% | 543,047 | 359,700 | 196.2% | $1,268.30万 | 加仓 |
| PRAX | PRAXIS PRECISION MEDICINES I | $2,306.27万 | 1.87% | 71,581 | -15,000 | -17.3% | -$483.28万 | 减仓 |
| PCVX | VAXCYTE INC | $2,491.07万 | 2.02% | 428,682 | 50,000 | 13.2% | $290.55万 | 加仓 |
| ALMS | ALUMIS INC | $2,673.45万 | 2.17% | 1,213,548 | 1,213,548 | — | $2,673.45万 | 新建仓 |
| CYTK | CYTOKINETICS INC 看涨期权 | $2,691.76万 | 2.19% | 408,400 | 117,500 | 40.4% | $774.44万 | 加仓 |
| BMY | BRISTOL-MYERS SQUIBB CO 看跌期权 | $3,032.50万 | 2.46% | 500,000 | -300,000 | -37.5% | -$1,819.50万 | 重新持有 |
| ABVX | ABIVAX SA 看涨期权 | $3,265.90万 | 2.65% | 293,300 | 168,200 | 134.5% | $1,872.91万 | 加仓 |
| CYTK | CYTOKINETICS INC 看跌期权 | $3,628.35万 | 2.95% | 550,500 | 550,500 | — | $3,628.35万 | 新建仓 |
| KOD | KODIAK SCIENCES INC | $4,825.21万 | 3.92% | 1,265,795 | 546,008 | 75.9% | $2,081.38万 | 加仓 |
| IWM | ISHARES TR 看跌期权 | $4,960.00万 | 4.03% | 200,000 | 200,000 | — | $4,960.00万 | 新建仓 |
| QQQ | INVESCO QQQ TR 看跌期权 | $5,771.80万 | 4.69% | 100,000 | 100,000 | — | $5,771.80万 | 新建仓 |
| — | TERNS PHARMACEUTICALS INC 看跌期权 | $6,326.40万 | 5.14% | 1,200,000 | 1,200,000 | — | $6,326.40万 | 新建仓 |
| — | TERNS PHARMACEUTICALS INC | $7,678.02万 | 6.23% | 1,456,378 | -140,000 | -8.8% | -$738.08万 | 减仓 |
| XBI | SPDR SERIES TRUST 看跌期权 | $1.02亿 | 8.30% | 800,000 | -50,000 | -5.9% | -$638.65万 | 减仓 |